Danish food ingredients firm Danisco has extended the deadline for its offer for all the remaining shares of US based biotechnology company Genencor to 19 April at 5pm New York time.

The offer previously was to expire on Wednesday 6 April 2005.

Danisco and its subsidiaries currently own approximately 41.6% of the outstanding shares of common stock of Genencor and have a contingent agreement with Eastman Chemical Company to buy its approximately 41.6% holding of Genencor common stock at US$15 per share. Danisco, through DH Subsidiary, is offering to purchase the balance of the outstanding shares of Genencor at $19.25 per share in cash.

Danisco has extended the expiration date of the tender offer due to further delay in the finalisation of the competition review of these transactions by regulators in Germany, it said.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.